Serological survey of antibodies to influenza A viruses in a group of people without a history of influenza vaccination

Clinical Microbiology and Infection

Volumn 17, Issue 9, 2011, Pages 1347-1349

  Chen, Y ^a   Zheng, Q ^a   Yang, K ^b   Zeng, F ^a   Lau, S Y ^c   Wu, W L ^c   Huang, S ^a   Zhang, J ^a   Chen, H ^c   Xia, N ^a  

^a XIAMEN UNIVERSITY   (China)

^b Xiamen International Travel Health Care Centre   (China)

^c THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Antibody; H9N2; Influenza; Pandemic H1N1; Prevalence

Indexed keywords

INFLUENZA VIRUS A H1N1 ANTIBODY; INFLUENZA VIRUS A H3N2 ANTIBODY; INFLUENZA VIRUS A H5N1 ANTIBODY; INFLUENZA VIRUS A H6N1 ANTIBODY; INFLUENZA VIRUS H9N2 ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

2009 H1N1 INFLUENZA; ANTIBODY DETECTION; ARTICLE; CHINA; CONTROLLED STUDY; EPIDEMIC; HEMAGGLUTINATION INHIBITION TEST; HUMAN; HUMAN TISSUE; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H9N2; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; SEROLOGY; VIRUS NEUTRALIZATION;

AVIAN INFLUENZA VIRUS; INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 80051877111     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2011.03538.x     Document Type: Article

References (11)

1. Chen H, Wang Y, Liu W et al. Serologic survey of pandemic (h1n1) 2009 virus, guangxi province, china. Emerg Infect Dis 2009; 15: 1849-1850.
2. Hancock K, Veguilla V, Lu X et al. Cross-reactive antibody responses to the 2009 pandemic h1n1 influenza virus. N Engl J Med 2009; 361: 1945-1952.
3. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M. Incidence of 2009 pandemic influenza a h1n1 infection in england: a cross-sectional serological study. Lancet 2010; 375: 1100-1108.
4. Mak GC, Choy PW, Lee WY, Wong AH, Ng KC, Lim W. Sero-immunity and serologic response to pandemic influenza a (h1n1) 2009 virus in hong kong. J Med Virol 2010; 82: 1809-1815.
5. Chen MI, Lee VJ, Lim WY et al. Influenza a(h1n1) seroconversion rates and risk factors among distinct adult cohorts in singapore. JAMA 2009; 303: 1383-1391.
6. Itoh Y, Shinya K, Kiso M et al. In vitro and in vivo characterization of new swine-origin h1n1 influenza viruses. Nature 2009; 460: 1021-1025.
7. Malik Peiris JS. Avian influenza viruses in humans. Rev Sci Tech 2009; 28: 161-173.
8. Wu WL, Chen Y, Wang P et al. Antigenic profile of avian h5n1 viruses in asia from 2002 to 2007. J Virol 2008; 82: 1798-1807.
9. Chen Y, Qin K, Wu WL et al. Broad cross-protection against h5n1 avian influenza virus infection by means of monoclonal antibodies that map to conserved viral epitopes. J Infect Dis 2009; 199: 49-58.
10. Deng Y, Pang XH, Yang P et al. Serological survey of 2009 h1n1 influenza in residents of Beijing, China. Epidemiol Infect 2011; 139: 52-58.
11. Xu KM, Smith GJ, Bahl J et al. The genesis and evolution of h9n2 influenza viruses in poultry from southern china, 2000 to 2005. J Virol 2007; 81: 10389-10401.